DIOS Discovers a Major Gold Target in Volcanics Hosting a Large Airborne IP on K2, WSW of Azimut’s Discovery
June 01, 2021 07:35 ET
|
DIOS Exploration Inc.
MONTREAL, June 01, 2021 (GLOBE NEWSWIRE) -- Dios Exploration Inc. is very pleased to have uncovered a major 3 km long gold glacial train (B-horizon and boulders) targeting a significant source in a...
Worldwide Regenerative Medicine Industry to 2030 - Market Analysis and Demand Forecasts
June 01, 2021 07:33 ET
|
Research and Markets
Dublin, June 01, 2021 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Market Research Report: By Type (Cell Therapy, Gene Therapy, Tissue Engineered Products), Application (Musculoskeletal, Wound...
Purpose Investments lance le Fonds de pension Longévité, le premier fonds commun de placement à revenu à vie au monde
June 01, 2021 07:32 ET
|
Purpose Investments Inc.
TORONTO, 01 juin 2021 (GLOBE NEWSWIRE) -- Purpose Investments Inc. (« Purpose ») est ravie d’annoncer le lancement du Fonds de pension Longévité (le « Fonds Longévité » ou « le Fonds »), le premier...
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter and Fiscal Year Ended March 31, 2021
June 01, 2021 07:31 ET
|
Immunovant
Immunovant plans to resume clinical development of IMVT-1401 in Myasthenia Gravis (MG) and Warm Autoimmune Hemolytic Anemia (WAIHA) as well as initiate two additional mid-to-late stage studies in the...
Celldex Announces Acceptance of Abstract for CDX-0159 Phase 1b Results in Inducible Urticaria for Late-Breaking Presentation at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress 2021
June 01, 2021 07:31 ET
|
Celldex Therapeutics, Inc.
HAMPTON, N.J., June 01, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that an abstract describing results from the Phase 1b study of CDX-0159 in patients with...
Iovance Biotherapeutics to Present at Upcoming Conferences
June 01, 2021 07:30 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today...
Flooring Market revenue to hit $480 Bn by 2027; Global Market Insights Inc.
June 01, 2021 07:30 ET
|
Global Market Insights, Inc
Selbyville, Delaware, June 01, 2021 (GLOBE NEWSWIRE) -- Global Market Insights Inc. has recently added a new report on the flooring market which estimates the market valuation for flooring will...
Mirati Therapeutics and Zai Lab Enter Into a Collaboration to Develop and Commercialize Adagrasib in Greater China
June 01, 2021 07:30 ET
|
Zai Lab Limited
Zai Lab obtains the right to develop and exclusively commercialize adagrasib in mainland China, Hong Kong, Macau and TaiwanMirati to receive an upfront payment of $65 million, up to approximately $273...
REPEAT -- Clean Power Announces Transition to Single Purpose Business
June 01, 2021 07:30 ET
|
Clean Power Capital Corp.
VANCOUVER, British Columbia and IRVINE, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- Clean Power Capital Corp. (NEO: MOVE)(FWB: 2K6)(OTC: MOTNF) (“Clean Power” or the “Company” or "MOVE"). Clean Power...
Orgenesis to Present at the Summer Solstice Conference - Best Ideas from the Buy-Side on June 2nd
June 01, 2021 07:30 ET
|
Orgenesis Inc.
GERMANTOWN, Md., June 01, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene...
- June 15, 2024 08:57 ET MULTIMEDIA UPDATE -- Rygen Technologies Launches Next-Gen Supply Chain Solution: AI-enabled TMS
- June 14, 2024 21:21 ET Pik'r Range Picking Robot Enhances U.S. Open Experience at Pinehurst